Evidence map›Paper›PMID 25389034›Full record

ArticleMucosal immunology2015

Intestinal immunopathology is associated with decreased CD73-generated adenosine during lethal infection.

V Francois, H Shehade, V Acolty, N Preyat, P Delrée, M Moser, G Oldenhove

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Mucosal immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 31 citations in OpenAlex.

  1. Ticagrelor IncreasesInternational journal of molecular sciences · 2020
    Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Symbiotic combination ofFrontiers in microbiology · 2024
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

V FrancoisDepartment of Molecular Biology, Laboratory of Immunobiology, Université Libre de Bruxelles, Gosselies, Belgium.
H ShehadeDepartment of Molecular Biology, Laboratory of Immunobiology, Université Libre de Bruxelles, Gosselies, Belgium.
V AcoltyDepartment of Molecular Biology, Laboratory of Immunobiology, Université Libre de Bruxelles, Gosselies, Belgium.
N PreyatDepartment of Molecular Biology, Laboratory of Immunobiology, Université Libre de Bruxelles, Gosselies, Belgium.
P DelréeInstitut de Pathologie et Génétique, Gosselies, Belgium.
M MoserDepartment of Molecular Biology, Laboratory of Immunobiology, Université Libre de Bruxelles, Gosselies, Belgium.
G OldenhoveDepartment of Molecular Biology, Laboratory of Immunobiology, Université Libre de Bruxelles, Gosselies, Belgium.
Université Libre de Bruxelles · BEInstitute of Pathology and Genetics · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ectonucleotidases CD39 and CD73 sequentially degrade the extracellular ATP pool and release immunosuppressive adenosine, thereby regulating inflammatory responses. This control is likely to be critical in the gastrointestinal tract where high levels of ATP are released in particular by commensal bacteria. The aim of this study was therefore to evaluate the involvement of the adenosinergic regulation in the intestine of mice in steady-state conditions and on acute infection with Toxoplasma gondii. We show that both conventional (Tconv) and regulatory (Treg) CD4(+) T lymphocytes express CD39 and CD73 in the intestine of naive mice. CD73 expression was downregulated during acute infection with T. gondii, leading to impaired capacity to produce adenosine. Interestingly, the expression of adenosine receptors was maintained and treatment with receptor agonists limited immunopathology and dysbiosis, suggesting that the activation of adenosine receptors may constitute an efficient approach to control intestinal inflammation associated with decreased ectonucleotidase expression.

Indexed as

5'-NucleotidaseAdenosineAnimalsAntigens, CDApyraseDisease Models, AnimalGene ExpressionGene Expression RegulationIntestinal DiseasesMiceMice, KnockoutReceptor, Adenosine A2AReceptor, Adenosine A2BT-Lymphocyte SubsetsToxoplasmaTransforming Growth Factor beta5'-NucleotidaseAdenosineAntigens, CDApyraseCD39 antigenReceptor, Adenosine A2AReceptor, Adenosine A2BTransforming Growth Factor betaTretinoin

Identifiers

PMID25389034
OpenAlexW2014896352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.